Related Experiment Videos
The Lescol Intervention Prevention Study (LIPS): start all patients on statins early after PCI
Adrian W Messerli1, Herbert D Aronow, Dennis L Sprecher
1Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, OH 44195, USA.
Cleveland Clinic Journal of Medicine
|June 28, 2003
Abstract:
The Lescol Intervention Prevention Study (LIPS) was the first randomized trial to show a significant reduction in the risk of cardiac events in patients started on fluvastatin immediately after a successful percutaneous coronary intervention. The benefit was independent of baseline cholesterol levels. The results suggest that all patients should be discharged on lipid-lowering therapy after a percutaneous coronary intervention. Currently, this is seldom done.